Nurix Therapeutics Inc (NAS:NRIX)
$ 15.12 -0.78 (-4.91%) Market Cap: 923.34 Mil Enterprise Value: 753.69 Mil PE Ratio: 0 PB Ratio: 4.41 GF Score: 67/100

Nurix Therapeutics Inc at the ASH Annual Meeting Transcript

Dec 12, 2023 / 04:30AM GMT
Release Date Price: $8.29 (-1.43%)
Jason Kantor Nurix Therapeutics
Inc. - Chief Business Officer

Okay, great. Let's get started. My name is Jason Kantor. I'm Chief Business Officer here at nerd therapeutics. I'd like to welcome everyone here who's in the room in San Diego and to all the folks on the webcast. Welcome to nourish therapeutics, ASH 2023 analyst event. We've got a lot of data to share with you tonight. It was a good day here at ASH with the posters for 2.275948, and I'd like to welcome up to the podium. Neurodex is President and CEO. Dr. Arthur Sands. Arthur.

Arthur Sands Nurix Therapeutics
Inc. - President & CEO

Thanks, Jason. And I'd also like to add my words of welcome to everyone and been a very exciting ASH 2023 for generics. We had a couple of major presentations at this conference, and we'll be talking about those tonight.

Before I get started, I'd like to just remind everyone we will be making certain forward-looking statements, and we refer you to our filings regarding our risk factors with the SEC. So we will be talking about two molecules tonight. And Merix

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot